Evidence map›Paper›PMID 30147700›Full record

ArticleFrontiers in immunology2018

Allergic Asthma Favors

Arnaud Machelart, Georges Potemberg, Laurye Van Maele, Aurore Demars, Maxime Lagneaux, Carl De Trez, Catherine Sabatel, Fabrice Bureau, Sofie De Prins, Pauline Percier and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Exacerbation ofVirulence · 2021
    Article
  5. Frontiers in microbiology · 2021
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Arnaud MachelartUnité de Recherche en Biologie des Microorganismes, Laboratoire d'Immunologie et de Microbiologie, NAmur Research Institute for Life Sciences (NARILIS), Université de Namur, Namur, Belgium.
Georges PotembergUnité de Recherche en Biologie des Microorganismes, Laboratoire d'Immunologie et de Microbiologie, NAmur Research Institute for Life Sciences (NARILIS), Université de Namur, Namur, Belgium.
Laurye Van MaeleInstitute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium.
Aurore DemarsUnité de Recherche en Biologie des Microorganismes, Laboratoire d'Immunologie et de Microbiologie, NAmur Research Institute for Life Sciences (NARILIS), Université de Namur, Namur, Belgium.
Maxime LagneauxUnité de Recherche en Biologie des Microorganismes, Laboratoire d'Immunologie et de Microbiologie, NAmur Research Institute for Life Sciences (NARILIS), Université de Namur, Namur, Belgium.
Carl De TrezDepartment of Molecular and Cellular Interactions, Vlaams Interuniversitair Instituut voor Biotechnologie, Vrije Universiteit Brussel, Brussels, Belgium.
Catherine SabatelLaboratory of Cellular and Molecular Immunology, GIGA- Research & WELBIO, University of Liège, Liège, Belgium.
Fabrice BureauLaboratory of Cellular and Molecular Immunology, GIGA- Research & WELBIO, University of Liège, Liège, Belgium.
Sofie De PrinsImmunology Unit, Scientific Institute for Public Health (WIV-ISP), Brussels, Belgium.
Pauline PercierImmunology Unit, Scientific Institute for Public Health (WIV-ISP), Brussels, Belgium.
Olivier DenisImmunology Unit, Scientific Institute for Public Health (WIV-ISP), Brussels, Belgium.
Fabienne JurionImmunology Unit, Scientific Institute for Public Health (WIV-ISP), Brussels, Belgium.
Marta RomanoImmunology Unit, Scientific Institute for Public Health (WIV-ISP), Brussels, Belgium.
Jean-Marie VanderwindenLaboratory of Neurophysiology, Université Libre de Bruxelles, Brussels, Belgium.
Jean-Jacques LetessonUnité de Recherche en Biologie des Microorganismes, Laboratoire d'Immunologie et de Microbiologie, NAmur Research Institute for Life Sciences (NARILIS), Université de Namur, Namur, Belgium.
Eric MurailleUnité de Recherche en Biologie des Microorganismes, Laboratoire d'Immunologie et de Microbiologie, NAmur Research Institute for Life Sciences (NARILIS), Université de Namur, Namur, Belgium.
University of Namur · BEInstitut Scientifique de Santé Publique · BEUniversité Libre de Bruxelles · BEUniversity of Liège · BEVlaams Instituut voor Biotechnologie · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic asthma is a chronic Th2 inflammatory disease of the lower airways affecting a growing number of people worldwide. The impact of infections and microbiota composition on allergic asthma has been investigated frequently. Until now, however, there have been few attempts to investigate the impact of asthma on the control of infectious microorganisms and the underlying mechanisms. In this work, we characterize the consequences of allergic asthma on intranasal (i.n.) infection by

Indexed as

AlternariaAnimalsAntigens, DermatophagoidesAntigens, FungalAsthmaBrucellaBrucellosisCD4-Positive T-LymphocytesDermatophagoides farinaeHypersensitivityInterleukin-10Interleukin-4LungMacrophages, AlveolarMiceMice, Inbred BALB CAntigens, DermatophagoidesAntigens, FungalInterleukin-10Interleukin-4STAT6 Transcription Factorallergic asthmaBrucella melitensisbrucellosisinfectionMycobacterium tuberculosisStreptococcus pneumoniae

Identifiers

PMID30147700
PMCPMC6095999
OpenAlexW2886447931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.